Nguyen, Stephanie https://orcid.org/0000-0003-2291-5693
Isabelle,
Funding for this research was provided by:
Hannah Block
Article History
Received: 22 April 2025
Accepted: 18 July 2025
First Online: 25 August 2025
Declarations
:
: The patient’s name is a pseudonym, used to protect her privacy. The journal is aware of the real name and address of the anonymised author, who has consented for the article to be published without her name attached. This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by either of the authors.
: Stephanie Nguyen has participated in expert board committees, training, seminars and conference committees sponsored by AbbVie, AstraZeneca, Gilead, Jazz Pharma, Neovii, Novartis and Sanofi. Isabelle declares that she has no competing interests.